Khusan Khalikulov1, Abrol Mansurov1, Saidorifkhon Murtazaev1, Sandjar Babadjanov1
1Republican Specialized Scientific Practical Medical Center of Surgery, Tashkent, Uzbekistan
Hybrid coronary revascularization (HCR) combines left internal mammary artery (LIMA)–left anterior descending artery (LAD) bypass with percutaneous intervention of non-LAD vessels. The purpose of this study was to compare outcomes of hybrid coronary revascularization to conventional coronary artery bypass graft (CABG).
20 patients who underwent HCR were compared with 50 patients who underwent conventional CABG by the period of 2014-2016. The results were estimated by the intraoperative and in hospital mortality, myocardial infarction, and stroke. These 20 patients of HCR group consequently underwent to the percutaneous intervention in the period of time of one week after coronary surgery.
We have included following patients to the HCR group, these are low ejection fraction, severe multivessel lesions and diabetes mellitus. Direct results of operations were following: in-hospital complications were lower after HCR versus CABG group, such as perioperative myocardial infarction and mortality. One patient of CABG group had the acute left ventricular insufficiency which lead to the death. HCR was associated with shorter hospital stay compared with CABG group.
HCR may represent a safe, less invasive alternative to conventional CABG at patients with the various complicated forms of ischemic heart disease.